Insider · CIK 0001846984

Weis Holger

Reports to the SEC for 2 companies · FORT LAUDERDALE, FL

sec.gov

Transactions

Companies

Filings

CIK

0001846984

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	TCRTAlaunos Therapeutics, Inc.A Award	CEO	AAward	+23.6K sh	$0.74	+$17.5K	49,047
2026-08-06	TCRTAlaunos Therapeutics, Inc.A Award	CEO	AAward	+4,363 sh	$2.01	+$8,769.63	25,483
2026-07-23	TCRTAlaunos Therapeutics, Inc.A Award	CEO	AAward	+4,568 sh	$1.92	+$8,770.56	21,120
2026-06-30	TCRTAlaunos Therapeutics, Inc.A Award	CEO	AAward	+3,880 sh	$2.26	+$8,768.8	16,552
2026-06-12	TCRTAlaunos Therapeutics, Inc.A Award	CEO	AAward	+7,761 sh	$2.26	+$17.5K	12,672
2026-06-02	JUNSJUPITER NEUROSCIENCES, INC. · Stock OptionA Award	Director	AAward	+100K sh	—	—	100,000
2026-05-22	TCRTAlaunos Therapeutics, Inc.A Award	CEO	AAward	+3,700 sh	$2.37	+$8,769	4,911
2025-08-18	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CEO	AAward	+13.7K sh	—	—	13,676
2025-07-02	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CEO	AAward	+130K sh	—	—	130,000
2025-06-02	JUNSJUPITER NEUROSCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+85.8K sh	—	—	96,581
2025-06-02	JUNSJUPITER NEUROSCIENCES, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−85.8K sh	—	—	0
2025-04-13	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CEO	AAward	+10.9K sh	—	—	10,904
2025-01-22	JUNSJUPITER NEUROSCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10.8K sh	—	—	10,781
2025-01-22	JUNSJUPITER NEUROSCIENCES, INC. · Convertible NotesM Exercise/Conversion	Director	MExercise/Conversion	−10.8K sh	$2.80	−$30.2K	10,781
2024-06-06	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CEO	AAward	+19.2K sh	—	—	19,200
2024-06-06	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CEO	AAward	+4,524 sh	—	—	4,524
2023-06-06	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CEO	AAward	+100K sh	—	—	100,000
2022-06-22	TCRTAlaunos Therapeutics, Inc.A Award	CEO	AAward	+40K sh	—	—	160,167
2022-06-22	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CEO	AAward	+100K sh	—	—	100,000
2021-09-01	TCRTAlaunos Therapeutics, Inc.P Purchase	CEO	PPurchase	+50K sh	$1.83	+$91.5K	120,167
2021-03-04	TCRTAlaunos Therapeutics, Inc.A Award	CEO	AAward	+4,167 sh	—	—	70,167
2021-03-04	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	CEO	AAward	+31.3K sh	—	—	31,250
2021-03-04	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	CEO	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Oct 84
Weis Holger0001193125-26-417970
SEC(opens sec.gov)
Aug 114
Weis Holger0001193125-26-344682
SEC(opens sec.gov)
Jul 274
Weis Holger0001193125-26-318105
SEC(opens sec.gov)
Jul 134
Weis Holger0001493152-26-033013
SEC(opens sec.gov)
Jul 24
Weis Holger0001193125-26-295004
SEC(opens sec.gov)
Jun 174
Weis Holger0001193125-26-274305
SEC(opens sec.gov)
Jun 44
Weis Holger0001493152-26-027354
SEC(opens sec.gov)
May 274
Weis Holger0001193125-26-241999
SEC(opens sec.gov)
Aug 204
Weis Holger0000950170-25-110530
SEC(opens sec.gov)
Jul 74
Weis Holger0000950170-25-094383
SEC(opens sec.gov)
Apr 154
Weis Holger0000950170-25-054432
SEC(opens sec.gov)
Jan 244
Weis Holger0001493152-25-003549
SEC(opens sec.gov)
Jun 104
Weis Holger0000950170-24-071401
SEC(opens sec.gov)
Jun 84
Weis Holger0000899243-23-014910
SEC(opens sec.gov)
Jun 244
Weis Holger0000899243-22-023977
SEC(opens sec.gov)
Sep 34
Weis Holger0001209191-21-054828
SEC(opens sec.gov)

Companies

Address

501 E LAS OLAS BLVD SUITE 300

FORT LAUDERDALE, FL, 33301